首页> 外国专利> Seelective estrogen receptors in combination with sexual steroid precursors for pharmaceutical compositions

Seelective estrogen receptors in combination with sexual steroid precursors for pharmaceutical compositions

机译:选择性雌激素受体结合性类固醇前体,用于药物组合物

摘要

Novel methods for the medical treatment and/or inhibition of the development of breast cancer, hypercholesterolemia, hyperlipidemia or atherosclerosis in susceptible warmblooded animals including humans involving administration of selective estrogen receptor modulator and an amount of a sex steroid precursor selected from the group consisting of dehydroepiandrosterone, dehydroepiandrosterone sulfate, androst-5-ene-3²,17²-diol, and compounds converted in vivo to one of the foregoing precursors. Further administration of bisphosphonates in combination with selective estrogen receptor modulators and/or sex steroid precursors is disclosed. Pharmaceutical compositions for delivery of active ingredients and kits useful to the invention are disclosed.
机译:在包括人类在内的易感温血动物中治疗和/或抑制乳腺癌,高胆固醇血症,高脂血症或动脉粥样硬化发展的新方法,涉及施用选择性雌激素受体调节剂和一定量的选自甾体脱氢表雄酮的性类固醇,硫酸脱氢表雄酮,雄烯-5-烯-3 2,17 2-二醇以及在体内转化为前述前体之一的化合物。公开了双膦酸盐与选择性雌激素受体调节剂和/或性类固醇前体的组合的进一步给药。本发明公开了用于递送活性成分的药物组合物和试剂盒。

著录项

  • 公开/公告号HU230495B1

    专利类型

  • 公开/公告日2016-09-28

    原文格式PDF

  • 申请/专利权人 ENDORECHERCHE INC.;

    申请/专利号HU20010003345

  • 发明设计人 LABRIE FERNAND;

    申请日1999-06-10

  • 分类号A61K31/565;C07D333/56;A61K31/133;A61K31/381;A61K31/40;A61K31/4025;A61K31/403;A61K31/404;A61K31/4436;A61K31/4453;A61K31/453;A61K31/475;A61K31/56;A61K31/568;A61K31/5685;A61K31/57;A61K31/66;A61K45;A61K45/06;A61P3/06;A61P9/10;A61P15;A61P15/02;A61P19/10;A61P21;A61P35;C07D209/10;C07D311/60;

  • 国家 HU

  • 入库时间 2022-08-21 14:26:07

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号